Is There Evidence for the Specificity of Closed-Loop Brain Training in the Treatment of Internalizing Disorders? A Systematic Review

Overview

Journal Front Neurosci

Date 2022 Apr 1

PMID 35360168

Authors

Tyson Michael Perez

Jerin Mathew

Paul Glue

Divya B Adhia

Dirk De Ridder

Affiliations

Soon will be listed here.

Abstract

Introduction: Internalizing disorders (IDs), e.g., major depressive disorder (MDD), posttraumatic stress disorder (PTSD), obsessive-compulsive disorder (OCD) are the most prevalent psychopathologies experienced worldwide. Current first-line therapies (i.e., pharmacotherapy and/or psychotherapy) offer high failure rates, limited accessibility, and substantial side-effects. Electroencephalography (EEG) guided closed-loop brain training, also known as EEG-neurofeedback (EEG-NFB), is believed to be a safe and effective alternative, however, there is much debate in the field regarding the existence of specificity [i.e., clinical effects specific to the modulation of the targeted EEG variable(s)]. This review was undertaken to determine if there is evidence for EEG-NFB specificity in the treatment of IDs.

Methods: We considered only randomized, double-blind, sham-controlled trials. Outcomes of interest included self/parent/teacher reports and clinician ratings of ID-related symptomatology.

Results: Of the four reports (total participant number = 152) meeting our eligibility criteria, three had point estimates suggesting small to moderate effect sizes favoring genuine therapy over sham, however, due to small sample sizes, all 95% confidence intervals (CIs) were wide and spanned the null. The fourth trial had yet to post results as of the submission date of this review. The limited overall number of eligible reports (and participants), large degree of inter-trial heterogeneity, and restricted span of ID populations with published/posted outcome data (i.e., PTSD and OCD) precluded a quantitative synthesis.

Discussion: The current literature suggests that EEG-NFB may induce specific effects in the treatment of some forms of IDs, however, the evidence is very limited. Ultimately, more randomized, double-blind, sham-controlled trials encompassing a wider array of ID populations are needed to determine the existence and, if present, degree of EEG-NFB specificity in the treatment of IDs.

Systematic Review Registration: [https://www.crd.york.ac.uk/prospero], identifier [CRD42020159702].

References

Thibault R, Lifshitz M, Raz A . The self-regulating brain and neurofeedback: Experimental science and clinical promise. Cortex. 2015; 74:247-61. DOI: 10.1016/j.cortex.2015.10.024. View

Orndorff-Plunkett F, Singh F, Aragon O, Pineda J . Assessing the Effectiveness of Neurofeedback Training in the Context of Clinical and Social Neuroscience. Brain Sci. 2017; 7(8). PMC: 5575615. DOI: 10.3390/brainsci7080095. View

Arns M, Heinrich H, Strehl U . Evaluation of neurofeedback in ADHD: the long and winding road. Biol Psychol. 2013; 95:108-15. DOI: 10.1016/j.biopsycho.2013.11.013. View

Tolin D, Davies C, Moskow D, Hofmann S . Biofeedback and Neurofeedback for Anxiety Disorders: A Quantitative and Qualitative Systematic Review. Adv Exp Med Biol. 2020; 1191:265-289. DOI: 10.1007/978-981-32-9705-0_16. View

Bandelow B, Michaelis S . Epidemiology of anxiety disorders in the 21st century. Dialogues Clin Neurosci. 2015; 17(3):327-35. PMC: 4610617. View

Sitaram R, Ros T, Stoeckel L, Haller S, Scharnowski F, Lewis-Peacock J . Closed-loop brain training: the science of neurofeedback. Nat Rev Neurosci. 2016; 18(2):86-100. DOI: 10.1038/nrn.2016.164. View

James A, James G, Cowdrey F, Soler A, Choke A . Cognitive behavioural therapy for anxiety disorders in children and adolescents. Cochrane Database Syst Rev. 2015; (2):CD004690. PMC: 6491167. DOI: 10.1002/14651858.CD004690.pub4. View

Schoenberg P, David A . Biofeedback for psychiatric disorders: a systematic review. Appl Psychophysiol Biofeedback. 2014; 39(2):109-35. DOI: 10.1007/s10484-014-9246-9. View

Chisholm D, Flisher A, Lund C, Patel V, Saxena S, Thornicroft G . Scale up services for mental disorders: a call for action. Lancet. 2007; 370(9594):1241-52. DOI: 10.1016/S0140-6736(07)61242-2. View

10.

Kessler R, Angermeyer M, Anthony J, de Graaf R, Demyttenaere K, Gasquet I . Lifetime prevalence and age-of-onset distributions of mental disorders in the World Health Organization's World Mental Health Survey Initiative. World Psychiatry. 2008; 6(3):168-76. PMC: 2174588. View

11.

Koprivova J, Congedo M, Raszka M, Prasko J, Brunovsky M, Horacek J . Prediction of treatment response and the effect of independent component neurofeedback in obsessive-compulsive disorder: a randomized, sham-controlled, double-blind study. Neuropsychobiology. 2013; 67(4):210-23. DOI: 10.1159/000347087. View

12.

Choi S, Chi S, Chung S, Kim J, Ahn C, Kim H . Is alpha wave neurofeedback effective with randomized clinical trials in depression? A pilot study. Neuropsychobiology. 2010; 63(1):43-51. DOI: 10.1159/000322290. View

13.

Arns M, Batail J, Bioulac S, Congedo M, Daudet C, Drapier D . Neurofeedback: One of today's techniques in psychiatry?. Encephale. 2017; 43(2):135-145. DOI: 10.1016/j.encep.2016.11.003. View

14.

Kerson C . A proposed multisite double-blind randomized clinical trial of neurofeedback for ADHD: need, rationale, and strategy. J Atten Disord. 2013; 17(5):420-36. DOI: 10.1177/1087054713482580. View

15.

Haidt J, Allen N . Scrutinizing the effects of digital technology on mental health. Nature. 2020; 578(7794):226-227. DOI: 10.1038/d41586-020-00296-x. View

16.

Pilkington K, Boshnakova A, Clarke M, Richardson J . "No language restrictions" in database searches: what does this really mean?. J Altern Complement Med. 2005; 11(1):205-7. DOI: 10.1089/acm.2005.11.205. View

17.

Kotov R, Krueger R, Watson D, Achenbach T, Althoff R, Bagby R . The Hierarchical Taxonomy of Psychopathology (HiTOP): A dimensional alternative to traditional nosologies. J Abnorm Psychol. 2017; 126(4):454-477. DOI: 10.1037/abn0000258. View

18.

Demyttenaere K, Bruffaerts R, Posada-Villa J, Gasquet I, Kovess V, Lepine J . Prevalence, severity, and unmet need for treatment of mental disorders in the World Health Organization World Mental Health Surveys. JAMA. 2004; 291(21):2581-90. DOI: 10.1001/jama.291.21.2581. View

19.

Keyes K, Gary D, OMalley P, Hamilton A, Schulenberg J . Recent increases in depressive symptoms among US adolescents: trends from 1991 to 2018. Soc Psychiatry Psychiatr Epidemiol. 2019; 54(8):987-996. PMC: 7015269. DOI: 10.1007/s00127-019-01697-8. View

20.

Buchan H, Sunderland M, Carragher N, Batterham P, Slade T . Investigating age-related differences in responses to screening items for internalising disorders in three national surveys. J Affect Disord. 2013; 152-154:229-36. DOI: 10.1016/j.jad.2013.09.015. View